In reply

Affiliations

¹ Northwest Permanente, Portland, OR; The University of Texas Health Science Center at Houston, Houston, TX.
² University of Maryland, Baltimore, MD.
³ The University of Texas Health Science Center at Houston, Houston, TX.

Comment

Ryan P Radecki et al. Ann Emerg Med. 2019 Nov.

. 2019 Nov;74(5):727.

doi: 10.1016/j.annemergmed.2019.05.035.

¹ Northwest Permanente, Portland, OR; The University of Texas Health Science Center at Houston, Houston, TX.
² University of Maryland, Baltimore, MD.
³ The University of Texas Health Science Center at Houston, Houston, TX.

No abstract available

Comment on

Adventures With Andexanet Alfa in Efficacy, Effectiveness, and One-Armed Studies: May 2019 Annals of Emergency Medicine Journal Club.
Radecki RP, Spiegel RJ. Radecki RP, et al. Ann Emerg Med. 2019 May;73(5):545-547. doi: 10.1016/j.annemergmed.2019.03.015. Ann Emerg Med. 2019. PMID: 31029291 Free PMC article.
Andexanet Response.
Milling TJ Jr, Connolly S. Milling TJ Jr, et al. Ann Emerg Med. 2019 Nov;74(5):724-725. doi: 10.1016/j.annemergmed.2019.05.033. Ann Emerg Med. 2019. PMID: 31668247 Free PMC article. No abstract available.
FDA Approval of Andexanet Alfa Based on a Single-Arm Trial: If There Is a Villain, Who Is It?
Pallin DJ. Pallin DJ. Ann Emerg Med. 2019 Nov;74(5):725-727. doi: 10.1016/j.annemergmed.2019.05.034. Ann Emerg Med. 2019. PMID: 31668248 No abstract available.